Abstract
Development of a vaccine to protect against infection with HIV-1 or to enhance antiviral immunity after HIV-1 has established itself in the host, is a major challenge to researchers. The virus has evolved many successful ways of evading the immune system which include its innate ability to mutate immunodominant regions and to lie dormant for many years as an integrated part of the human genome. In addition, the major target of HIV-1 is the CD4+ T-helper cell (Lane and Fauci, 1985). This cell plays a central role in the induction of effector cells responses to viruses. Early on following infection CD4+ Th cells are decreased in function and gradually are also decreased in number. Since these helper cell are required for specific immune responses to protein antigens, in terms of antibody and cytotoxic T cell responses (CTL), the host loses ability to attack the virus and to ward off other infections. The vaccines that are currently in clinical trials involve the use of proteins which probably require normal function of CD4+ Th in order that primary and secondary immune responses take place.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blay, R., Hernandez, D., Betts, M., Clerici, M., Lucey, D.R., Hendrix, C.R., Hoffman, T. and Golding, B., 1992, Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFNy: Implications for use of Brucella abortus as a carrier in development of vaccines, Aids Res, and Human Retroviruses, 8:479
Dimitrov, D.S., Hillman, K., Manischewitz, J., Blumenthal, R. and Golding, H., 1992, Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein, J.Virol., 66: 132
Dimitrov, D.S., Hillman, K., Manischewitz, J., Blumenthal, R. and Golding, B., 1992, Correlation between kinetics of soluble CD4 interactions with HIV-l-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS, AIDS, 6:249
Finkelman, F.D., Katona, I.D., Mosmann, T.R. and Coffman, R.L., 1988, IFN-y regulates the isotypes of Ig secreted during in vivo humoral immune responses, J.Immunol., 140:1022
Ginsburg, N.N., Zhivie Vakzini, p 270-283, in: “Zhivie Vakzini”, N.N. Ginsburg (ed.) Medizina, 1969, Moscow
Golding, B., Chang, S.P., Golding, H., Jones, R.E., Pratt, K.L., Burger, D.R. and Rittenberg, M.B., 1981, Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro, J.Immunol., 127:220
Golding, B., Muchmore, A.V. and Blaese, R.M., 1984, Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP- Brucella abortusbehaves as a T-independent type 1 antigen in humans, J.Immunol., 133:2966
Golding, H., D’Souza, M.P., Bradac, J., Mathieson, B. and Fast, P., 1994, Neutralization of HIV-1 (meeting report), AIDS Research and Human Retroviruses, 10:633
Goldstein, J., Hoffman, T., Frasch, C., Lizzio, E.L., Beining, P.R., Hochstein, D., Lee, Y.L., Angus, R.D. and Golding, B., 1992, Lipopolysaccharide from Brucella abortusis less toxic than that from E.coli, suggesting the possible use of B.abortusas a carrier in vaccines, Infection and Immunity, 60:1385
Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L. and Locksley, R.M., 1991, Reciprocal expression of interferon gamma or IL4 during the resolution or regression of leishmaniasis. Evidence for expansion of distinct T cell subsets, J.Exp.Med., 169:59
Inman, J.K., 1975, Thymus-independent antigens: The preparation of covalent, hapten-Ficoll conjugates, J.Immunol., 114:704
Johnson, W.J., Steplewski, Z., Koprowski, H. and Adams, D.O., 1985, Destructive interactions between murine macrophages tumor cells and antibodies of the IgG2a isotype, p. 75, in: Mechanisms of cell-mediated cytotoxicity II, P. Henkart and E. Martz (eds.), Plenum, New York
Krutzsch, H.C. and Inman, J.K., 1993, N-Isopropyliodoacetamide in the reduction and alkylation of proteins: Use in microsequence analysis, Anal.Biochem., 209:109
Lane, H.C. and Fauci, A.S., 1985, Immunologic abnormalities in the acquired immunodeficiency syndrome, Ann.Rev.Immunol., 3:477
Mach, H., Middaugh, C.R. and Lewis, R.V., 1992, Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native protein, Anal.Biochem., 200:74
Mond, J.J., Farrar, J., Paul, W.E., Fuller-Farrar, J., Schaeffer, M. and Howard, M., 1983, T cell dependence and factor reconstitution of in vitroantibody responses to TNP- B.abortusand TNP-Ficoll: Restoration of depleted responses with chromatographed fractions of a T cell-derived factor, J.Immunol., 131:633
Mosmann, T.R. and Coffman, R.L., 1989, TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties, Ann.Rev.Immunol., 7:145
Salgame, P., Abrams, J.S., Clayberger, C., Goldstein, H. and Bloom, B., 1991, Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cells clones, Science, 254:279
Slack, J., Der-Balian, G.P., Nahm, M. and Davie, J.M., 1980, Subclass restriction of murine antibodies.II.The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency, J.Immunol., 151:853
Snapper, C.M. and Paul, W.E., 1987, Interferon-y and B cell stimulatory factor-1 reciprocally regulate Ig isotype production, Science, 236:944
Street, N.E., Schumacher, J.H., Fong, T.A.T., Bass, H., Fiorentino, D.F., Leverah, J.A. and Mossman, T.R., 1990, Heterogeneity of mouse helper T cells: Evidence from bulk cultures and limiting dilution cloning for precursors of Thl and Th2 cells, J.Immunol., 144:1629
Unkeless, J., 1977, The presence of two receptors on mouse macrophages: evidence from a variant cell line and differential trypsin sensitivity, J.Exp.Med., 145:931
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press, New York
About this chapter
Cite this chapter
Golding, B., Inman, J., Golding, H. (1995). Design of Vaccines for the Induction of Antibody Responses in Th-Cell Deficient Individuals. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccines. Nato Science Series, vol 282. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0357-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0357-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8014-6
Online ISBN: 978-1-4613-0357-2
eBook Packages: Springer Book Archive